Rob Etherington is the founder of Clene Nanomedicine. Clene Nanomedicine has raised $200M in total funding. Based in Salt Lake City, Utah, United States.
Rob Etherington is the founding CEO and President of Clene Nanomedicine, a biopharmaceutical company focused on developing therapies for neurodegenerative diseases. He has secured over $200 million in equity financing and has more than 30 years of experience in sales, marketing, and leadership within the technology sector.
Full founder directory · Investor directory · Company funding database · Fundraising library